HOOKIPA PHARMA INC. Revenue
HOOKIPA PHARMA INC. reported Revenue of $2.00 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-05-15
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-03-31 was $2.00M, a 94.52% decline year-over-year.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-12-31 was $1.35M, a 81.72% decline year-over-year.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-09-30 was $4.70M, a 31.51% decline year-over-year.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-06-30 was $1.29M, a 51.85% decline year-over-year.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $43.95M, a 118.32% increase from fiscal 2023.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $20.13M, a 41.27% increase from fiscal 2022.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $14.25M, a 22.76% decline from fiscal 2021.
- HOOKIPA PHARMA INC. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $18.45M, a 5.80% decline from fiscal 2020.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-03-31 | $2.00M 10-Q · filed 2025-05-15 | $3.36M derived: sum of 2 quarters · filed 2025-05-15 | $8.06M derived: sum of 3 quarters · filed 2025-05-15 | $9.35M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.06M derived: sum of 2 quarters · filed 2025-02-28 | $7.35M derived: sum of 3 quarters · filed 2025-02-28 | $43.95M 10-K · filed 2025-02-28 |
| 2024-09-30 | $4.70M 10-Q · filed 2024-11-14 | $5.99M derived: sum of 2 quarters · filed 2024-11-14 | $42.59M 10-Q · filed 2024-11-14 | $50.00M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $1.29M 10-Q · filed 2024-08-08 | $37.89M 10-Q · filed 2024-08-08 | $45.30M derived: sum of 3 quarters · filed 2025-05-15 | $52.16M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $36.60M 10-Q · filed 2025-05-15 | $44.01M derived: sum of 2 quarters · filed 2025-05-15 | $50.87M derived: sum of 3 quarters · filed 2025-05-15 | $53.55M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $7.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $14.27M derived: sum of 2 quarters · filed 2025-02-28 | $16.95M derived: sum of 3 quarters · filed 2025-02-28 | $20.13M 10-K · filed 2025-02-28 |
| 2023-09-30 | $6.87M 10-Q · filed 2024-11-14 | $9.55M derived: sum of 2 quarters · filed 2024-11-14 | $12.72M 10-Q · filed 2024-11-14 | $20.55M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.68M 10-Q · filed 2024-08-08 | $5.86M 10-Q · filed 2024-08-08 | $13.68M derived: sum of 3 quarters · filed 2025-02-28 | $15.91M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.18M 10-Q · filed 2024-05-09 | $11.00M derived: sum of 2 quarters · filed 2025-02-28 | $13.23M derived: sum of 3 quarters · filed 2025-02-28 | $15.98M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.06M derived: sum of 2 quarters · filed 2025-02-28 | $12.80M derived: sum of 3 quarters · filed 2025-02-28 | $14.25M 10-K · filed 2025-02-28 |
| 2022-09-30 | $2.23M 10-Q · filed 2023-11-09 | $4.98M derived: sum of 2 quarters · filed 2023-11-09 | $6.42M 10-Q · filed 2023-11-09 | $10.32M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $2.75M 10-Q · filed 2023-08-10 | $4.19M 10-Q · filed 2023-08-10 | $8.09M derived: sum of 3 quarters · filed 2024-03-22 | $11.96M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $1.45M 10-Q · filed 2023-05-11 | $5.34M derived: sum of 2 quarters · filed 2024-03-22 | $9.21M derived: sum of 3 quarters · filed 2024-03-22 | $14.59M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $7.77M derived: sum of 2 quarters · filed 2024-03-22 | $13.15M derived: sum of 3 quarters · filed 2024-03-22 | $18.45M 10-K · filed 2024-03-22 |
| 2021-09-30 | $3.87M 10-Q · filed 2022-11-14 | $9.25M derived: sum of 2 quarters · filed 2022-11-14 | $14.55M 10-Q · filed 2022-11-14 | $19.72M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $5.38M 10-Q · filed 2022-08-11 | $10.68M 10-Q · filed 2022-08-11 | $15.84M derived: sum of 3 quarters · filed 2022-08-11 | $19.88M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $5.30M 10-Q · filed 2022-05-16 | $10.46M derived: sum of 2 quarters · filed 2022-05-16 | $14.50M derived: sum of 3 quarters · filed 2022-05-16 | $21.19M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $5.16M 10-K · filed 2021-03-18 | $9.20M derived: sum of 2 quarters · filed 2021-11-10 | $15.89M derived: sum of 3 quarters · filed 2021-11-10 | $19.58M 10-K · filed 2023-03-15 |
| 2020-09-30 | $4.04M 10-Q · filed 2021-11-10 | $10.72M derived: sum of 2 quarters · filed 2021-11-10 | $14.42M 10-Q · filed 2021-11-10 | $18.04M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $6.68M 10-Q · filed 2021-08-12 | $10.38M 10-Q · filed 2021-08-12 | $14.00M derived: sum of 3 quarters · filed 2021-08-12 | $16.04M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $3.70M 10-Q · filed 2021-05-12 | $7.31M derived: sum of 2 quarters · filed 2021-05-12 | $9.35M derived: sum of 3 quarters · filed 2021-05-12 | $13.40M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $3.62M 10-K · filed 2021-03-18 | $5.66M derived: sum of 2 quarters · filed 2021-03-18 | $9.71M derived: sum of 3 quarters · filed 2021-03-18 | $11.94M 10-K · filed 2022-03-24 |
| 2019-09-30 | $2.04M 10-K · filed 2021-03-18 | $6.09M derived: sum of 2 quarters · filed 2021-03-18 | $8.32M 10-Q · filed 2020-11-12 | $13.40M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | $4.05M 10-K · filed 2021-03-18 | $6.29M 10-Q · filed 2020-08-13 | $11.37M derived: sum of 3 quarters · filed 2021-03-18 | $13.27M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $2.23M 10-K · filed 2021-03-18 | $7.32M derived: sum of 2 quarters · filed 2021-03-18 | $9.21M derived: sum of 3 quarters · filed 2021-03-18 | $9.86M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | $5.08M 10-K · filed 2020-03-19 | $6.98M derived: sum of 2 quarters · filed 2020-03-19 | $7.63M derived: sum of 3 quarters · filed 2020-03-19 | $7.63M 10-K · filed 2021-03-18 |
| 2018-09-30 | $1.90M 10-K · filed 2020-03-19 | $2.55M derived: sum of 2 quarters · filed 2020-03-19 | $2.55M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $649.00K 10-K · filed 2020-03-19 | $649.00K 10-Q · filed 2019-08-12 |